- ►annals.org [PDF] JM Brophy, L Joseph, JL Rouleau - Annals of internal medicine, 2001 - Am Coll Physicians Purpose: Congestive heart failure is an important cause of pa- tient morbidity
and mortality. Although several randomized clini- cal trials have compared
ß-blockers with placebo for treatment of congestive heart failure, a meta- ... Cited by 266 - Related articles - BL Direct - All 5 versions
- ►sinaimed.org [PDF] D Sources, D Extraction, D Synthesis - Ann Intern Med, 2001 - Am Coll Physicians Purpose: Congestive heart failure is an important cause of pa- tient morbidity
and mortality. Although several randomized clini- cal trials have compared
ß-blockers with placebo for treatment of congestive heart failure, a meta- ... Related articles - All 4 versions
A Bouzamondo, JS Hulot, P Sanchez, M … - Fundamental & clinical pharmacology, 2001 - pt.wkhealth.com We performed a review of all clinical trials that compare beta-blockers vs.
placebo in chronic heart failure. Beta-blockers with different pharmacological
profiles have been tested, mainly metoprolol, bisoprolol, bucindolol and ... Cited by 42 - Related articles - All 7 versions
- ►oxfordjournals.org MC Shibata, MD Flather, D Wang - European Journal of Heart Failure, 2001 - Elsevier Heart failure is a common condition that carries a high burden of mortality and
morbidity. Several randomised trials have evaluated the effects of beta blockers
in heart failure. This paper gives a systematic overview of published ... Cited by 82 - Related articles - All 4 versions
- ►onlinejacc.org S Goldstein, B Fagerberg, Å Hjalmarson, J … - Journal of the American College of Cardiology, 2001 - Elsevier This study analyzed the effect of the beta 1 -selective beta-blocker metoprolol
succinate controlled release/extended release (CR/XL) once daily on mortality,
hospitalizations and tolerability in patients with severe heart failure. Cited by 105 - Related articles - BL Direct - All 8 versions
- ►onlinejacc.org P Jong, C Demers, RS McKelvie, PP Liu - Journal of the American College of Cardiology, 2002 - Elsevier We sought to determine the effect of angiotensin receptor blockers (ARBs) on
mortality and hospitalization in patients with heart failure (HF). ... There is
uncertainty regarding the efficacy of ARBs as substitute or adjunctive ... Cited by 143 - Related articles - BL Direct - All 14 versions
- ►oxfordjournals.org [PDF] RN Doughty, A Rodgers, N Sharpe, S … - European heart journal, 1997 - Eur Soc Cardiology Page 1. European Heart Journal (1997) 18, 560-565 Effects of beta-blocker therapy
on mortality in patients with heart failure A systematic ... Cited by 219 - Related articles - BL Direct - All 3 versions
- ►oxfordjournals.org [PDF] S Bandyopadhyay, MS O'Mahony - Age and ageing, 2002 - Br Geriatrics Soc Five percent of all hospital medical admissions are patients with heart failure.
The incidence is about one new case per 1000 of the general population per year,
increasing to )10 per 1000 in those aged 085 years. Although the evidence ... Cited by 2 - Related articles - BL Direct - All 5 versions
RT Tsuyuki, FA McAlister, KK Teo - Drugs &# 38; Aging, 2000 - ingentaconnect.com Abstract Despite the availability of angiotensin converting enzyme (ACE)
inhibitors for patients with congestive heart failure (CHF), mortality and
morbidity remains unacceptably high. CHF is thought to progress as a result ... Cited by 8 - Related articles - BL Direct - All 3 versions
